Φορτώνει......
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Given the multi-faceted pathogenesis of atherosclerosis in type 2 diabetes mellitus (T2DM), it is likely that interventions to mitigate this risk must address cardiovascular (CV) risk factors beyond glucose itself. Sodium glucose cotransporter-2 (SGLT-2) inhibitors are newer antihyperglycaemic agent...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Diab Vasc Dis Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4361459/ https://ncbi.nlm.nih.gov/pubmed/25589482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164114559852 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|